GO
Loading...

Biotech Firm Gilead Hammered

Friday, 17 Feb 2012 | 1:00 PM ET

Gilead Sciences shares are getting hammered today after disappointing test results on one of its Hepatitis C drugs, with CNBC's Seema Mody.